Matching Each Patient With Their Most Effective Therapy

Scipher Medicine is partnering with leading payers, providers, and pharma companies along the healthcare value chain to bring precision medicine to autoimmune diseases.

Scipher leverages its proprietary platform (a map of protein-protein interactions that occur in human cells) and AI to develop blood-based diagnostic tests. The tests identify a patient’s unique disease biology to predict response to specific pharmacological therapies, and potentially match each patient to their most effective therapy.

Investing partner / fund: